KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer

Conditions:   Breast Cancer;   Gastric/Gastroesophageal Junction Cancer Intervention:   Drug: KN026 Sponsor:   Jiangsu Alphamab Biopharmaceuticals Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials